The House of Representatives Committee on Appropriations by a 31-18 vote sent to the House floor their version of the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2015. In addition, the House committee issued a report directing the FDA’s Office of Cosmetics and Colors (OCAC) to reply to industry petitions regarding lipstick lead by March 15, 2015.
The Committee voiced their disappointment in the fact that OCAC has not responded to petition requests (read the petitions here) and urged OCAC to make this a priority. As cosmetics companies and manufactures await OCAC’s response, the industry remains vulnerable to opposition from the Campaign for Safe Cosmetics. Although the FDA conducted test of more than 400 lipstick products and found no consumer safety risks, the industry and Congress want the FDA to respond to ease any remaining concerns and prevent any future concerns.
Additionally, in light of China’s importance to U.S.-based manufacturers and consumers, the Committee directed the FDA to establish bilateral technical dialogue with Chinese regulators. Likewise, the Committee directed the FDA to promote international regulatory harmonization and trade in cosmetic products by supporting international trade negotiations on cosmetics in trade agreements.